Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Raised to $230.00
Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) had its price target lifted by Truist Financial from $220.00 to $230.00 in a research note released on Thursday,Benzinga reports. Truist Financial currently has a buy rating on the specialty pharmaceutical company’s stock. Other equities analysts have also recently issued reports about the stock. Wells Fargo & Company raised […]
Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) had its price target lifted by Truist Financial from $220.00 to $230.00 in a research note released on Thursday,Benzinga reports. Truist Financial currently has a buy rating on the specialty pharmaceutical company’s stock. Other equities analysts have also recently issued reports about the stock. Wells Fargo & Company raised […]
